Actavis plc insider trades: Furiex Pharmaceuticals (FURX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Actavis plc reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 2, 2014 | FURX | ↑ Buy | 11,169,066 | $95.00 | $1.06B | Direct | Jul 7, 2014 (5d) |
| Mar 7, 2014 | CBRX | ↓ Sell | 1,400,000 | $5.76 | $8.1M | Indirect | Mar 11, 2014 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Actavis plc's insider trades
Actavis plc is a 10% owner of Furiex Pharmaceuticals (FURX). Since Mar 7, 2014, it has reported 1 open-market purchase worth $1.06B and 1 sale worth $8.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FURX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.